During the past decade, "Specialized Hospital for Active Treatment of Pneumo-Phthisiatric Diseases-Haskovo" Ltd conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 2 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 2 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in ""Specialized Hospital for Active Treatment of Pneumo-Phthisiatric Diseases-Haskovo" Ltd" #1 sponsor was "Pfizer" with 6 trials, followed by "Amgen" with 1 trials sponsored, "Enanta Pharmaceuticals, Inc" with 1 trials sponsored, "Genentech, Inc." with 1 trials sponsored and "Hoffmann-La Roche" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in ""Specialized Hospital for Active Treatment of Pneumo-Phthisiatric Diseases-Haskovo" Ltd" #1 collaborator was "PPD" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in ""Specialized Hospital for Active Treatment of Pneumo-Phthisiatric Diseases-Haskovo" Ltd" are "COVID-19" (4 trials), "Child, Hospitalized" (1 trials), "Chronic Obstructive Pulmonary Disease" (1 trials), "Coronavirus Disease 2019 (COVID-19)" (1 trials) and "Gastric Cancer" (1 trials). Many other conditions were trialed in ""Specialized Hospital for Active Treatment of Pneumo-Phthisiatric Diseases-Haskovo" Ltd" in a lesser frequency.

Most popular intervention types in ""Specialized Hospital for Active Treatment of Pneumo-Phthisiatric Diseases-Haskovo" Ltd" are "Drug" (10 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Ritonavir" (5 trials), "PF-07321332" (3 trials), "Nirmatrelvir" (2 trials) and "Placebo for nirmatrelvir" (2 trials). Other intervention names were less common.

The vast majority of trials in ""Specialized Hospital for Active Treatment of Pneumo-Phthisiatric Diseases-Haskovo" Ltd" are 10 trials for "All" genders.

Currently, there are NaN active trials in ""Specialized Hospital for Active Treatment of Pneumo-Phthisiatric Diseases-Haskovo" Ltd". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in "Specialized Hospital for Active Treatment of Pneumo-Phthisiatric Diseases-Haskovo" Ltd, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in "Specialized Hospital for Active Treatment of Pneumo-Phthisiatric Diseases-Haskovo" Ltd, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".